Artificial bone refers to bone-like material created in a laboratory that can be used in bone grafts, to replace human bone that was lost due to severe fractures, diseases, and others. Bone grafts are used as a filler and scaffold to facilitate bone formation and promote wound healing. These grafts are bioresorbable and have no antigen-antibody reaction. These bone grafts act as a mineral reservoir which induces new bone formation. Bone substitutes can be either derived from biological products such as ceramics, composite, polymer, hydroxyapatite, and others.
Market Dynamics
The increasing number of product launches is expected to drive the global artificial bone market. For instance, in October 2016, Stryker has announced the launch of its handheld bone graft delivery system. The LITe BIO Delivery System is approved for use in spinal fusion surgeries to deliver autograft, allograft, and synthetic material. The LITe BIO Delivery System was approved by the U.S. Foods and Drugs Administration in July 2017 for to improve visualization, to work under fluoroscopy.
However, growth of the global artificial bone market is expected to be hampered over the forecast period, owing to high cost of spinal fusion surgeries and joint replacement/ reconstruction. For instance, according to the MedSurge, a pharmaceutical company report 2018, the cost of the spine fusion surgeries in Indian hospitals ranged from around US$ 4,800 to US$ 7,800 and the cost of the scoliosis spine surgery in India ranged from US$ 10,500 to US$ 11,500 in year 2018.
Key features of the study:
- This report provides in-depth analysis of the global artificial bone market size (US$ Mn), and compound annual growth rate (CAGR) for the forecast period: 2021-2028, considering 2020 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global artificial bone market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Medtronic Plc., Johnson & Johnson, Baxter International Inc., Smith & Nephew plc, Stryker Corporation., NuVasive, Inc., Allosource, Curasan, Inc., Ziacom Medical SLU, Orthofix International N.V., Biomatlante, and DSM.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global artificial bones market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for artificial bones market, research and consulting firms, new entrants, and financial analysts.
Detailed Segmentation:
- Global Artificial Bone Market, By Material:
- Ceramics
- Composite
- Polymer
- Hydroxyapatite
- Others
- Global Artificial Bone Market, By Application:
- Spinal Fusion
- Dental
- Craniomaxillofacial
- Joint Reconstruction
- Trauma and Extremities
- Global Artificial Bone Market, By End User:
- Hospitals
- Specialty Clinics
- Research Organization
- Global Artificial Bone Market, By Region:
- North America
- By Country:
- By Material:
- Ceramics
- Composite
- Polymer
- Hydroxyapatite
- Others
- By Application:
- Spinal Fusion
- Dental
- Craniomaxillofacial
- Joint Reconstruction
- Trauma and Extremities
- By End User:
- Hospitals
- Specialty Clinics
- Research Organization
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Material:
- Ceramics
- Composite
- Polymer
- Hydroxyapatite
- Others
- By Application:
- Spinal Fusion
- Dental
- Craniomaxillofacial
- Joint Reconstruction
- Trauma and Extremities
- By End User:
- Hospitals
- Specialty Clinics
- Research Organization
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Material:
- Ceramics
- Composite
- Polymer
- Hydroxyapatite
- Others
- By Application:
- Spinal Fusion
- Dental
- Craniomaxillofacial
- Joint Reconstruction
- Trauma and Extremities
- By End User:
- Hospitals
- Specialty Clinics
- Research Organization
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Material:
- Ceramics
- Composite
- Polymer
- Hydroxyapatite
- Others
- By Application:
- Spinal Fusion
- Dental
- Craniomaxillofacial
- Joint Reconstruction
- Trauma and Extremities
- By End User:
- Hospitals
- Specialty Clinics
- Research Organization
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Material:
- Ceramics
- Composite
- Polymer
- Hydroxyapatite
- Others
- By Application:
- Spinal Fusion
- Dental
- Craniomaxillofacial
- Joint Reconstruction
- Trauma and Extremities
- By End User:
- Hospitals
- Specialty Clinics
- Research Organization
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Material:
- Ceramics
- Composite
- Polymer
- Hydroxyapatite
- Others
- By Application:
- Spinal Fusion
- Dental
- Craniomaxillofacial
- Joint Reconstruction
- Trauma and Extremities
- By End User:
- Hospitals
- Specialty Clinics
- Research Organization
- Company Profiles
- Medtronic Plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Johnson & Johnson
- Baxter International Inc.
- Smith & Nephew plc
- Stryker Corporation
- NuVasive, Inc.
- Allosource
- Curasan, Inc.
- Ziacom Medical SLU
- Orthofix International N.V
- Biomatlante
- DSM
“*” marked represents similar segmentation in other categories in the respective section.
